Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Construction and Validation of a Prognostic Model of Metabolism-Related Genes Driven by Somatic Mutation in Bladder Cancer.

Frontiers in bioscience (Landmark edition) - 19 Oct 2023

Wei Liang, Ji Lina, Han Shuaihong, Xu Mingquan, Yang Xiaofeng

Abstract excerpt

BACKGROUND: Metabolic reprogramming is an important player in the prognosis of cancer patients. However, metabolism-related genes (MRGs) that are essential to the prognosis of bladder cancer (BLCA) are nor yet fully understood. The purpose of this study is to use bioinformatics methods to establish prognostic models based on MRGs in BLCA to screen potential biomarkers. METHODS: Based on the transcriptomic data...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers
Share to Mutation
Share to Oxidative Phosphorylation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Prognosis

Share to Urinary Bladder Neoplasms

Source

Identifiers

PMID: 37919060
DOI: 10.31083/j.fbl2810242

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Construction and Validation of a Prognostic Model of Metabolism-Related Genes Driven by Somatic Mutation in Bladder Cancer.PMID 37919060Read ↗

Construction and validation of a prognostic model of metabolism-related genes driven by somatic mutation in bladder cancerSemantic proximity Read ↗

Identification of Metabolic Reprogramming Related Gene Signature to Predict the Prognosis of Bladder Cancer PatientsSemantic proximity Read ↗

Identification of metabolism-associated genes and construction of a prognostic signature in bladder cancerSemantic proximity Read ↗

Epigenetic dysregulation-induced metabolic reprogramming fuels tumor progression in bladder cancerSemantic proximity Read ↗

Identification of metabolism-associated genes and construction of a prognostic signature in bladder cancerSemantic proximity Read ↗

Identification of a novel metabolism-related gene signature associated with the survival of bladder cancer.Semantic proximity Read ↗

Development and validation of a novel lipid metabolism-related gene prognostic signature and candidate drugs for patients with bladder cancerSemantic proximity Read ↗

Identification and Validation of a Novel Metabolism‑Related Prognostic Signature in Hepatocellular CarcinomaSemantic proximity Read ↗

Identification of a Novel Lipid Metabolism-Related Gene Signature in Prognosis of Bladder CancerSemantic proximity Read ↗

Metabolic reprogramming based on RNA sequencing of gemcitabine-resistant cells reveals the FASN gene as a therapeutic for bladder cancerSemantic proximity Read ↗

Comprehensive analysis of fatty acid metabolism-related genes in prognosis, tumor microenvironment infiltration and core gene identification of bladder cancerSemantic proximity Read ↗

A novel molecular classification based on TP53 mutation to predict bladder cancer prognosis and immunotherapy efficacySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.